A Potential Human Anti-Viral Science Coup: Zika Vaccine Candidate Now In Human Trials…

life-hvivo-seek-zika-phase-1b-2017This indeed is another hopeful sign — a public/private collaboration (with US and UK partners, as well) has resulted in the development of a broad range vaccine candidate for mosquito-born viral diseases — including, of course Zika.

As of yesterday, that vaccine candidate is in human trials in Bethesda, Maryland — in a study being run by the US NIH. Here’s a bit, from Medical Xpress:

. . . .The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched a Phase 1 clinical trial to test an investigational vaccine intended to provide broad protection against a range of mosquito-transmitted diseases, such as Zika, malaria, West Nile fever and dengue fever, and to hinder the ability of mosquitoes to transmit such infections.

The study, which is being conducted at the NIH Clinical Center in Bethesda, Maryland, will examine the experimental vaccine’s safety and ability to generate an immune response. . . .

I wish you all — of good will — nothing but the best, in all things. Do treat others as you would wish to be treated. . . smile. With this candidate, we are all our brothers’ and sisters’ keepers. . . . regardless of geopolitical borders.



There are no comments on this post.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: